Reactivation of SARS-CoV-2 infection following recovery from COVID-19

Zhihai Chen,Wen Xie,Ziruo Ge,Yajie Wang,Hong Zhao,Jingjing Wang,Yanli Xu,Wei Zhang,Meihua Song,Shuping Cui,Xiankun Wang,Calvin Q Pan,Calvin Q. Pan
DOI: https://doi.org/10.1016/j.jiph.2021.02.002
IF: 7.537
2021-05-01
Journal of Infection and Public Health
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Introduction</h3><p>Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had recovered from COVID-19 and determined its predictors.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>In this retrospective cohort study, patients with COVID-19 were followed up for at least 14 days after two consecutive negative SARS-CoV-2 polymerase chain reaction test results obtained ≥24 hours apart, and the frequency of SARS-CoV-2 reactivation was assessed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of the 109 patients, 29 (27%) experienced reactivation, and seven (24%) of these were symptomatic. The mean period for the real-time PCR tests for SARS-CoV-2 from negative to positive results was 17 days. Compared with patients without reactivation, those with reactivation were significantly younger and more likely to have a lymphocyte count of &lt;1500/µL (odds ratio [OR]: 0.34, 95% confidence interval [CI]: 0.12–0.94) and two or fewer symptoms (OR: 0.20, 95% CI: 0.07–0.55) during the initial episode.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Risk-stratified surveillance should be conducted among patients who have recovered from COVID-19.</p>
infectious diseases,public, environmental & occupational health
What problem does this paper attempt to address?